Studies presented at the American Diabetes Association's meeting in San Francisco took a deeper look at what the presence of fat does to overweight children. Researchers found that signs of trouble emerge early, with implications for the treatment of youths with type 1 diabetes, and those at risk of developing type 2 diabetes.
Childhood obesity is more than a “problem,” it’s an indicator that what’s gone wrong metabolically has set young people up for a host of health problems later on. What’s worse, once a child becomes overweight, it can be very hard to reverse either the weight gain or its effects.
Studies presented at Sunday morning’s session, “Fitness and Fatness in Youth With or At Risk of Diabetes,” revealed how much researchers are learning about the effects of excess weight in children and teenagers, right down to the cellular level.
The sessions reflected a larger message at the 74th Scientific Sessions of the American Diabetes Association, which conclude Tuesday in San Francisco, California: children are not “little adults.” Their bodies react differently to risk factors, and this reality must be taken into account when developing treatment for obesity and diabetes mellitus, both type 1 (T1DM) and type 2 (T2DM). Obesity’s rise, both in the United States and around the world, is especially problematic for T1DM youth, as they must take insulin which puts them at further risk of weight gain. Among the studies presented:
An audience member observed that that many of the results had implications for the emotionally charged issue of encouraging weight loss in younger girls; the commenter said data show girls who are overweight in their teens are more likely to skip insulin.
A sign of hope came from Curtis Harrod, MPH, of the University of Colorado, whose study examined the relationship between physical activity during pregnancy and infant birth weight and neonatal composition. Harrod found that there was little relationship between activity in the first two trimesters and neonatal composition, but that increased activity in the final trimester was associated with lower levels of neonatal adiposity. Thus, encouraging mothers who are at-risk of having overweight children to exercise more during pregnancy could have positive effects on the child at birth, and later in life.5
References
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More